Banner Logo

Pursuit Vascular is developing a family of products based on its patent-pending ClearGuard™ platform technology. The first product targets infections associated with hemodialysis catheters.

Dialysis catheter patients experience an average of 1.5 catheter-related infections per year. These infections greatly impact patient morbidity and mortality, resulting in approximately 23,000 deaths in the US and costing Medicare an estimated $1.5B each year.

Antimicrobial fluid locks have been clinically proven to reduce infection rates by 85% (Jaffer 2008), but are not available in the US due to safety concerns associated with fluid leaking into the patient’s bloodstream.

Pursuit Vascular's innovative ClearGuard™ technology is intended to capture all the benefits of antimicrobials without the associated issues. Each product is being designed to safely and cost-effectively prevent infection, resulting in substantial savings to the global healthcare system.

 

Tekne Award Logo

 

MN Cup Logo

WINNER 2009

 

LifeScience Alley New Technology Showcase Logo

WINNER

LifeScience Alley

2010

 

MarketPlace of Ideas Logo

GRAND PRIZE

Marketplace of Ideas

2010

 

Enterprise Institute Logo

FIRST PLACE

Innovation Expo

2010